4 Spam-Free Article(s) Found
May 17, 2019 - Celgene (CELG) obtains approval for the label expansion of oncology drugs Revlimid and Imnovid in Europe.
May 17, 2019 - Focus on prolific onshore and offshore resources is likely to back Hess' (HES) oil equivalent productions.
May 17, 2019 - New Strong Buy Stocks for May 17th
May 14, 2019 - Top Ranked Income Stocks to Buy for May 14th